GLG News by Lexapro Prescribers: Psychiatrists (US)

Creating a means of blocking nicotine from entering the brain might result in impaired cognition, memory, and concentration.

This acquisition seems to be all good...both financially for NightHawk and its shareholders and for the medical marketplace.

There has been much emphasis on the salutary effects of red wine...mostly via its resveratrol content.   I believe we are seducing a wine lover's contingent that doesn't need seducing..and the carrot may be over-rated.

While the antidepressant market is rife with generic forms of most major antidepressants, not all generics work equally well with all patients.  Examples are given to substantiate this point.

Although ADHD and SUD (Substance Use Disorder) are frequent comorbid conditions - both in adolescents and adults - sorting out an effective treatment strategy is usually extremely challenging.  The consequences of not recognizing ADHD and treating it early on, can have dire implications for the...

The current landscape in drug development is dominated by a handful of huge pharmaceutical companies and a huge number of biotechs...some more promising than others.  This inherent instability will lead to consolidation and several factors will determine the matchmaking.

The FDA's reaction to some preliminay data suggesting an increase in suicidal "ideation"  (not attempts or actual suicides) was an over-reaction.  Further data, such as provided by the described meta-analysis will restore a balance in perception.

It can be a costly mistake to generalize paradigms of disease across genders, races, and cultures.  A look at eating disorders brings this point home.

How government funding for stem cell research plays out may have repercussions for government funding of medical research in general...with unforeseen "chilling" consequences.

A new drug that will reportedly boost female sexual desire is racing through clinical trials.  Will women seek out this treatment and what will be the consequences.